Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria

K Kim, G Waterer, R Thomson, IA Yang, N Nashi… - Cytokine, 2014 - Elsevier
K Kim, G Waterer, R Thomson, IA Yang, N Nashi, DBA Tan, P Price
Cytokine, 2014Elsevier
Pulmonary disease due to non-tuberculous mycobacteria (NTM) is caused by several
species (particularly Mycobacterium avium, Mycobacterium intracellulare) that are abundant
in the environment. Th1 cytokines such as interferon (IFN)-γ are important in the control of
mycobacteria, but in vitro production of IFN-γ is not deficient in adult patients with pulmonary
NTM disease. Antibodies reactive with IFN-γ have been described in patients with
disseminated NTM disease, but it is not clear whether they are common in pulmonary …
Abstract
Pulmonary disease due to non-tuberculous mycobacteria (NTM) is caused by several species (particularly Mycobacterium avium, Mycobacterium intracellulare) that are abundant in the environment. Th1 cytokines such as interferon (IFN)-γ are important in the control of mycobacteria, but in vitro production of IFN-γ is not deficient in adult patients with pulmonary NTM disease. Antibodies reactive with IFN-γ have been described in patients with disseminated NTM disease, but it is not clear whether they are common in pulmonary disease. Here we show that patients with pulmonary NTM have a higher level of anti-IFN-γ and anti-GM-CSF antibodies than healthy controls, although some controls also have high levels. Levels of anti-IFN-γ antibodies did not correlate with levels of total immunoglobulin. Longitudinal studies are required to determine whether anti-cytokine autoantibodies are consequence rather than a cause of pulmonary NTM disease.
Elsevier